Key facts
- This page summarizes Linda M. Tharby's Form 4 filing for KORU Medical Systems, Inc. (KRMD).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 Mar 2025, 16:35.
Linda M. Tharby - 17 Mar 2025 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- KRMD
- Reported as of
- 17 Mar 2025
- Net transaction value
- -$109,918
- SEC form
- 4
- Accepted by SEC
- 21 Mar 2025, 16:35:57 UTC
- Prior SEC filing
- 30 Sep 2024
- Next SEC filing
- 23 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Linda Tharby
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Linda M. Tharby filed Form 4 for KORU Medical Systems, Inc. (KRMD) on 21 Mar 2025.
Change
- Previous filing in this sequence was filed on 30 Sep 2024.
- Current net transaction value: -$109,918.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KRMD
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +15,968
- Change %
- +1.5%
- Price
- $0.000000
- Shares after
- 1,085,411
- Date
- 17 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F4
KRMD
transaction
Common Stock
Tax liability
- Transaction value
- $25,547
- Shares
- -8,848
- Change %
- -0.82%
- Price
- $2.89
- Shares after
- 1,076,563
- Date
- 17 Mar 2025
- Ownership
- Direct
- Footnotes
- F2, F4
KRMD
transaction
Common Stock
Tax liability
- Transaction value
- $84,371
- Shares
- -29,813
- Change %
- -2.8%
- Price
- $2.83
- Shares after
- 1,046,750
- Date
- 19 Mar 2025
- Ownership
- Direct
- Footnotes
- F3, F4
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KRMD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -15,968
- Change %
- -25%
- Price
- Shares after
- 47,904
- Date
- 17 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,968
- Exercise price
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents common stock issued upon vesting of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock upon vesting.
Footnote F2
Represents shares withheld to satisfy tax obligations upon vesting of restricted stock units.
Footnote F3
Represents shares withheld to satisfy tax obligations upon vesting of previously issued restricted stock.
Footnote F4
Includes 200,000 in restricted stock awards that vest based on a schedule of the Company's market capitalization prior to 3/15/27; and 600,000 in restricted stock awards that vest based on a schedule of the Company's net sales growth targets for each of the fiscal years ended 12/31/22 through 12/31/25.
Footnote F5
This restricted stock unit award was granted under the Issuer's 2024 Omnibus Equity Incentive Plan. The units comprising the award vest in equal increments on March 15, 2025 and each first, second and third anniversaries thereof (each, a vesting date). Shares were withheld to satisfy applicable tax withholding obligations.
SEC remarks
The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person.